Adaptive Charge Initiation for Implantable Cardioverter-Defibrillator
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable cardiac rhythm management devices face challenges in efficiently adapting and delivering therapeutic therapy for recurring non-sustained arrhythmic episodes, particularly in ventricular tachycardia, due to the need for precise and timely intervention in life-threatening situations.
Innovation Solution
The implementation of an implantable cardiac rhythm management device with operational circuitry that determines the necessity of cardiac stimulus, initiates charging, and adjusts thresholds based on cardiac event analysis, ensuring appropriate therapy delivery by capturing and analyzing cardiac events, and modifying thresholds to prevent unnecessary charge initiations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If the device initiates charging operation upon detecting abnormal cardiac events, then the response time to potential life-threatening arrhythmias is reduced, but unnecessary charges may be initiated for non-malignant episodes
Solution Approach 1:
The patent implements dynamic threshold adjustment where the abnormal event threshold is modified based on recent charging history. When a charge is initiated, the threshold temporarily increases to prevent immediate re-charging during the same arrhythmic episode, allowing the system to adapt its sensitivity dynamically rather than using a fixed threshold
Solution Approach 2:
The system incorporates feedback mechanisms by monitoring whether abnormal events occur during charging operations and using this information to adjust future threshold behavior. The circuitry tracks charging events and uses this feedback to prevent unnecessary subsequent charges, creating a closed-loop control system that learns from past decisions
2Reliability
If the device monitors cardiac events continuously to ensure accurate therapy delivery, then the reliability of treatment indication is improved, but the device complexity and power consumption increase
Solution Approach 1:
The monitoring function is segmented into distinct operational phases: event detection, threshold evaluation, charging decision, and post-charging threshold adjustment. This segmentation allows the complex monitoring task to be divided into manageable functional blocks that can be implemented with simpler, dedicated circuitry for each phase
Solution Approach 2:
The system performs preliminary threshold adjustment before initiating charging operations. By pre-adjusting the abnormal event threshold based on predicted charging needs, the system simplifies real-time decision-making during critical moments and reduces the computational burden during high-stress operational phases
3Productivity
If the device delivers therapy promptly upon detecting malignant arrhythmias, then patient outcomes are improved, but inappropriate therapy delivery may occur for non-malignant conditions
Solution Approach 1:
The abnormal event threshold dynamically adjusts based on the device's charging state and recent history. When charging is initiated or recently completed, the threshold increases to prevent inappropriate re-charging, while returning to baseline sensitivity when not charging, thus adapting therapy delivery criteria to operational context
Solution Approach 2:
The patent introduces an intermediary threshold adjustment mechanism that acts as a buffer between event detection and therapy delivery decisions. This intermediary layer evaluates both the abnormal event detection and the charging state before finalizing therapy indication, preventing direct coupling that could lead to inappropriate therapy
Data Source
AI summary
Devices configured to perform an adaptive method for initiating charging of high power capacitors and delivering therapy to a patient after the patient experiences a non-sustained arrhythmia. The adaptive methods adjust persistence criteria used to analyze an arrhythmia prior to initiating a charging sequence to deliver therapy.